全文获取类型
收费全文 | 5198篇 |
免费 | 302篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 157篇 |
妇产科学 | 61篇 |
基础医学 | 999篇 |
口腔科学 | 103篇 |
临床医学 | 424篇 |
内科学 | 1007篇 |
皮肤病学 | 99篇 |
神经病学 | 450篇 |
特种医学 | 338篇 |
外科学 | 671篇 |
综合类 | 43篇 |
一般理论 | 1篇 |
预防医学 | 294篇 |
眼科学 | 125篇 |
药学 | 450篇 |
中国医学 | 6篇 |
肿瘤学 | 306篇 |
出版年
2022年 | 26篇 |
2021年 | 73篇 |
2020年 | 37篇 |
2019年 | 61篇 |
2018年 | 86篇 |
2017年 | 64篇 |
2016年 | 77篇 |
2015年 | 103篇 |
2014年 | 137篇 |
2013年 | 159篇 |
2012年 | 264篇 |
2011年 | 257篇 |
2010年 | 172篇 |
2009年 | 163篇 |
2008年 | 235篇 |
2007年 | 299篇 |
2006年 | 247篇 |
2005年 | 269篇 |
2004年 | 267篇 |
2003年 | 271篇 |
2002年 | 256篇 |
2001年 | 108篇 |
2000年 | 80篇 |
1999年 | 93篇 |
1998年 | 115篇 |
1997年 | 94篇 |
1996年 | 72篇 |
1995年 | 72篇 |
1994年 | 70篇 |
1993年 | 66篇 |
1992年 | 67篇 |
1991年 | 57篇 |
1990年 | 60篇 |
1989年 | 76篇 |
1988年 | 62篇 |
1987年 | 47篇 |
1986年 | 60篇 |
1985年 | 55篇 |
1984年 | 51篇 |
1983年 | 31篇 |
1982年 | 47篇 |
1981年 | 43篇 |
1980年 | 49篇 |
1979年 | 46篇 |
1978年 | 29篇 |
1977年 | 38篇 |
1976年 | 45篇 |
1975年 | 28篇 |
1973年 | 32篇 |
1969年 | 22篇 |
排序方式: 共有5568条查询结果,搜索用时 31 毫秒
1.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
2.
3.
4.
Dr. Med. Wolfgang Rutsch Horst Schmutzler 《Cardiovascular and interventional radiology》1986,9(5-6):245-252
Reestablishing myocardial perfusion during evolving myocardial infarction may limit the ultimate extent of infarction if viable
myocardial tissue is present when recanalization of the occluded vessel is achieved. This will result in improved left ventricular
function and decreased mortality. In addition to their therapeutic benefits, recanalization procedures have contributed greatly
to our knowledge of acute myocardial infarction. It has been demonstrated that myocardial infarction most often occurs after
thrombotic occlusion of a coronary artery. This has settled a controversy that has preoccupied cardiologists for decades.
Selective intracoronary administration of fibrinolytic agents is followed by recanalization in approximately 80% of cases.
Therapeutic failures are attributable to occlusion caused by other factors, to inactivation of streptokinase by high antibody
concentrations, and to insufficient concentrations of streptokinase at the thrombus as a results of unfavorable flow conditions.
This study is dedicated to Prof. Dr. Med. Horst Schmutzler on the occasion of his 60th birthday. 相似文献
5.
6.
To determine the relationship between severity of illness and mortality, therapeutic intervention score (TISS) and acute physiology score (APS) were determined on admission to the Surgical Intensive Care Unit (SICU). Patients were divided into survivors and nonsurvivors and differences were compared by chi-square analysis. The 1524 patients admitted to the SICU during a 12-month period had a mean TISS of 3.03 and a mean APS of 13. The average length of stay (LOS) was 3.75 days. Of the 1524 patients, 97 (6.4%) died. The number of nonsurvivors increased with higher TISS and APS scores (P less than 0.001). There were no deaths in the TISS Category 1 patients or in the APS 0-5 group. Mortality rates dramatically increased with APS greater than 20 (P less than 0.001). There were 1286 patients with APS less than 20, and 24 (2%) of these patients died, whereas 73 (31%) of 238 patients with APS greater than 20 died. Nonsurvivors had a mean TISS of 3.6, mean APS of 27, and LOS of 4.88 days, all of which totals were higher than the survivors' totals. In this study population, risk of death was one in three if the APS was greater than 20. These data indicate that TISS and APS scores are effective means of assessing mortality risk in SICU patients. 相似文献
7.
8.
Hans-Jürgen Möller Horst Müller Richard L. Borison Nina R. Schooler Guy Chouinard 《European archives of psychiatry and clinical neuroscience》1995,245(1):45-49
The hypothesis that differences in drug effects of risperidone and haloperidol on negative symptoms in schizophrenia are secondary to effects on positive, extrapyramidal, and depressive symptoms was investigated by means of an analysis of the data from the USA-Canada risperidone double-blind randomized clinical trial of 523 chronic schizophrenic patients. Regression analyses in the total sample and within treatment groups confirmed a strong relationship between changes in negative symptoms and the other variables studied (R2=0.50–0.51,p<0.001). Only depressive symptoms did not contribute significantly to these results (p>0.10). Path analysis showed that the greater mean change (p<0.05) of negative symptoms with risperidone compared to haloperidol could not be fully explained by correlations with favourable effects on positive and extrapyramidal symptoms. The relationship between shift in extrapyramidal symptoms and shift in negative symptoms failed to reach statistical significance; however, there was a clear tendency in the expected direction in both treatment groups. 相似文献
9.
Dr. James C. Garrelts Pharm.D. W. Dale Horst Ph.D. Beryl Silkey Sc.M. Dr. Suzanne Gagnon M.D. 《Pharmacotherapy》1994,14(4):438-445
Study Objectives . To characterize patient sociodemographics and health, describe vancomycin treatment parameters and clinician-rated outcomes, and determine costs associated with treatment including preparation and administration, adverse events, and toxicity. Design . A prospective study to develop a model for costs associated with antibiotic treatment (vancomycin). Setting . A community hospital. Patients . One hundred adults with active infections. Interventions . Mean duration of therapy was 10 days, and most patients received 2000 mg/day. Serum concentrations were monitored in two of three patients. Detailed cost analyses were completed on a subset of 26 patients selected at random from the overall sample. Measurements and Main Results . Sepsis and skin and skin structure infections were the most common indications for vancomycin therapy. Treatment was effective in 81 patients, failed in 9, and was not evaluable in 10. Thirty-eight percent of patients experienced adverse events attributable to the drug. Phlebitis was common, and red man syndrome, nephrotoxicity, and ototoxicity were infrequent. Conclusions . Total cost of vancomycin treatment for 100 patients was $30,251: $23,855 for preparation and administration, $1710 for monitoring serum concentrations, and $4686 for treating adverse reactions. Drug costs accounted for only 55% of the total cost. Vancomycin is safe and effective, but phlebitis is underreported and significantly affects cost. 相似文献
10.
Ohne Zusammenfassung 相似文献